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ABSTRACT
Objectives To test the impact on inequalities and 
uptake of the schools- based human papillomavirus (HPV) 
vaccination programme by stage of implementation of a 
new policy providing additional opportunities to consent.
Setting Two local authorities in the south- west of 
England.
Participants Young women (n=7129) routinely eligible for 
HPV vaccination aged 12–13 years during the intervention 
period (2017/2018 to 2018/2019 programme years).
Interventions Local policy change that included 
additional opportunities to provide consent (parental verbal 
consent and adolescent self- consent).
Outcomes Secondary analyses of cross- sectional 
intervention data were undertaken to examine uptake 
by: (1) receipt of parental written consent forms and; (2) 
percentage of unvaccinated young women by stage of 
implementation.
Results During the intervention period, 6341 (89.0%) 
eligible young women initiated the HPV vaccination 
series. Parental written consent forms were less likely 
to be returned where young women attended alternative 
education provider settings (p<0.001), belonged to non- 
white British ethnic groups (p<0.01) or more deprived 
quintiles (p<0.001). Implementation of parental verbal 
consent and adolescent self- consent reduced the 
percentage of unvaccinated young women from 21.3% to 
16.5% (risk difference: 4.8%). The effect was greater for 
young women belonging to the most deprived compared 
with the least deprived quintile (risk difference: 7.4% 
vs 2.3%, p<0.001), and for young women classified as 
Unknown ethnic category compared with white British 
young women (6.7% vs 4.2%, p<0.001). No difference 
was found for non- white British young women (5.4%, 
p<0.21).
Conclusions Local policy change to consent procedures 
that allowed parents to consent verbally and adolescents 
to self- consent overcame some of the barriers to 
vaccination of young women belonging to families less 
likely to respond to paper- based methods of gaining 
consent and at greater risk of developing cervical cancer.
Trial registration number 49 086 105.
INTRODUCTION
The human papillomavirus (HPV) vaccine 
currently used in England protects against 
infection from high- risk HPV types 16 and 
18 which cause cancers affecting the cervix, 
vulva, vagina, penis, anus and oral cavity. 
The vaccine also protects against types 6 and 
11 which cause 90% of genital warts. High 
coverage of the English HPV vaccination 
programme for young women aged 12–13 
years has been achieved. Recent evidence 
highlights the potential for HPV vaccina-
tion programmes to substantially reduce 
the incidence of cervical cancer.1 2 Based on 
emerging evidence for cost- effectiveness, in 
2019/2020 the HPV vaccination programme 
was expanded to include young men aged 
12–13 years.
Despite generally good coverage, without 
concerted efforts to address lower uptake 
among some populations, pre- existing dispar-
ities in the incidence of cervical cancer by 
ethnicity and deprivation may increase.3–5 
We previously identified lower uptake by area 
Strengths and limitations of this study
 ► This study uses routinely collected data to examine 
the impact of local policy changes on inequalities 
in uptake of the human papillomavirus vaccination 
programme.
 ► The intervention period (programme years 2017/2018–
2018/2019) was relatively short.
 ► Missing data on ethnicity could change the direction 
or size of the corresponding ORs.
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and among some population groups, including minority 
ethnic groups.6 Our research in schools with lower uptake 
showed complex socio- cultural factors can influence 
whether young women are vaccinated7 and the require-
ment for written parental consent may act as a barrier to 
some young women receiving the HPV vaccine.8
In the UK (comprising England, Scotland, Northern 
Ireland and Wales), consent for schools- based adoles-
cent vaccination programmes is usually obtained from 
parents or carers. Young people are provided with a form 
for their parent to sign and hand back to school before 
a vaccination session takes place. However, the UK legal 
framework allows young people to be vaccinated without 
parental consent provided they are deemed ‘Gillick 
competent’9 (ie. they have sufficient maturity and intel-
ligence to understand the nature and implications of the 
treatment). Findings from an evidence synthesis showed 
the implementation of adolescent self- consent proce-
dures could be prevented by local policies which favoured 
written parental consent, and the precedence given to 
professionals’ concerns about their reputations and rela-
tionships with parents.10
A local authority is an organisation officially respon-
sible for all public services and facilities in a particular 
area. To address concerns about lower uptake in two local 
authority areas in the south- west of England, a new policy 
(including parental verbal consent and adolescent self- 
consent) has been implemented.9 Implementation of 
the new consent procedures in one of the intervention 
areas appeared to improve uptake in contrast to trends 
of decreasing uptake among matched local authori-
ties.11 However, no evidence for an absolute increase, or 
reduction in inequalities by deprivation and ethnicity was 
found.
The aim of the current study is to further examine the 
impact of the consent procedures on HPV vaccine uptake. 
Specifically, we describe:
1. Receipt of parental written consent forms by school 
category, ethnicity and deprivation quintile.
2. Unvaccinated young women by stage of implementa-
tion of consent procedures, and by school category, 
ethnicity and deprivation quintile.
METHODS
This cross- sectional study was undertaken when the English 
vaccination programme was delivered routinely to young 
women only. Details of the evaluation and changes to the 
new local policy are provided in a published protocol.12
The new local policy (including consent procedures)
In brief, previously only young women who had returned 
a written parental consent form, indicating the parent 
or carer is willing for their daughter to receive the HPV 
vaccine, were administered the vaccine in the school 
setting. Under the new arrangements, all young women 
eligible for the vaccination, including those whose 
parents have provided written refusal, are asked to attend 
the session by the immunisation team. For those young 
women who do not have a returned parental written 
consent form, the immunisation nurse attempts to gain 
parental verbal consent over the telephone. If the parent 
cannot be contacted and the young woman expresses will-
ingness to be vaccinated, the immunisation nurse assesses 
the young woman’s competence and if they are deemed 
competent the young women will receive the vaccine. 
All young women who do not receive the vaccine on 
the day are given information about alternative options 
to receive the vaccination, such as through their family 
doctor or community- based clinics run by the immunisa-
tion team (online supplemental material 1). Parents are 
not routinely contacted again by the immunisation team.
We define stage of implementation of consent proce-
dures as the following: (1) ‘stage 1: parent written consent 
only’; (2) ‘stage 2: parent verbal consent and adolescent 
self- consent’ and; (3) ‘stage 3: community catch up clinics 
and family practice settings’. These stages represent 
sequential opportunities (in a single programme) for 
unvaccinated young women to receive the vaccine, rather 
than different time points.
Patient and public involvement
The Bristol Young Person’s Advisory Group (YPAG) 
(website: https:// generationr. org. uk/ bristol/) took 
part in preliminary discussions about self- consent proce-
dures, at which a group of 11 young people discussed 
self- consent for vaccination of those of secondary school 
age. Following this discussion, all voted in favour of self- 
consent preferably with parents being informed. The 
young people were overall positive about the documents 
which they thought provided the right amount of infor-
mation clearly. As a result of the feedback, some changes 
to the wording of the information and formatting were 
made. Members of the Bristol Youth Council (website: 
https://www. bristol. gov. uk/ youth- council- youth- mayors) 
were approached to participate in the study during 
recruitment. This resulted in an opportunity to obtain 
feedback on a proposal developed from the findings of 
the current study.
During the study, the lead researcher was also invited to 
deliver school- based information sessions about the HPV 
vaccine to year 7 students. The study researcher also led 
PSHE (Personal, Health, Social and Economic) lessons 
where year 8 students were able to find out about research 
and encouraged to debate issues around adolescent self- 
consent. Study findings are being shared with the YPAG 
and the Bristol City Youth Council at meetings to mark 
the end of the study.
Population
Two local authorities implementing the new consent 
procedures for the HPV vaccination programme in the 
south- west of England provided data. Records relating to 
young women eligible (born between 1 September 2004 
and 31 August 2006) for vaccination during programme 
years 2017/2018 and 2018/2019 and who were registered 
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with a general practice within the local authority bound-
aries were retrieved in July 2019 from the Child Health 
Information System.
Data extraction from the Child Health Information System
Prior to study commencement, permission to access an 
anonymised data extract was gained from the relevant 
organisations with responsibility for the data. In the 
UK, the Child Health Information System holds demo-
graphic and vaccination- related records for each young 
person registered with a family doctor which is a statutory 
requirement. The following data fields were extracted 
from records of the eligible population: (1) partial date 
of birth; (2) partial postcode; (3) ethnicity; (4) dates and 
location HPV vaccination administered and (5) name 
and corresponding identifying code of school.
School identifying codes were used to assign the local 
authority responsible for delivery of the HPV vaccine. 
Partial date of birth was used to allocate programme year 
the young woman was eligible to receive the HPV vaccine. 
Categories of school types were applied to each record: 
(1) comprehensive, non- fee paying; (2) private, fee paying 
and (3) alternative education provider, which included 
pupil referral units, young offender units, hospital educa-
tion service, specialist schools for students with significant 
additional needs and young women educated at home.
Individual records were classed as ‘received HPV 
vaccine’ if there was a record of at least one dose admin-
istered within the corresponding programme year the 
young woman was eligible. Postcodes from individual 
records were linked to the corresponding lower super 
output area. Deprivation score was assigned using the 
Index of Multiple Deprivation 2019 (a statistic on relative 
deprivation in small areas of England)13 and analysed as 
quintiles. Due to small numbers, ethnicity was grouped as 
follows: (1) white British; (2) non- white British and (3) 
unknown.
Records were excluded if the relevant school identi-
fying code was missing or invalid. Absence of recorded 
ethnicity was considered likely Missing Not At Random 
as absence of ethnicity data was associated with the 
outcome, school and deprivation variables. A complete 
case approach where records were excluded on the basis 
of missing ethnicity is not recommended.14 Instead, the 
‘unknown’ category was assigned to missing ethnicity data 
to minimise the risk of bias.
Data extraction from the immunisation team’s records of 
consent
Additional data were sought from the school immunisa-
tion team’s electronic and paper- based records relating to 
vaccination consent during the intervention period. This 
included: (1) return of parental consent forms (‘yes’ or 
‘no’) and; (2) stage of implementation of consent proce-
dures. We classified each record as belonging to one of 
the following stages of the consent procedure: (1) ‘stage 
1: parent written consent only’; (2) ‘stage 2: parent verbal 
consent and adolescent self- consent’ and (3) ‘stage 3: 
community catch up clinics and family practice settings’. 
Records could not be assigned to more than one stage of 
consent category.
Data linkage
The data extracted from the immunisation team’s records 
were linked to the Child Health Information System 
using deterministic data linkage methods by a member of 
staff at Health Intelligence. An anonymised version of the 
data extract was securely transferred to researchers at the 
University of Bristol.
ANALYSIS
Return of parental consent forms
Logistic univariable analyses and likelihood ratio tests 
were performed to explore factors associated with return 
of parental consent form. The following explanatory vari-
ables for analysis were selected a priori: school category, 
ethnicity and deprivation quintile. A multivariable logistic 
regression model was developed. We used cluster- robust 
errors in the final model to allow for the possibility of 
clustering within schools.
Unvaccinated young women by stage of implementation of 
consent procedures
To describe the decrease in unvaccinated young women at 
each stage of implementation of the consent procedures, 
we calculated risk differences (difference in two propor-
tions) with 95% Confidence Intervals. The risk difference 
shows the absolute effect of implementation of each stage 
of the consent procedure. We considered the following 
risk differences (risk reductions) by: (1) percentage 
of young women unvaccinated during ‘stage 1: parent 
written consent only’ minus percentage of young women 
unvaccinated during ‘stage 1’ and ‘stage 2: parent verbal 
consent and adolescent self- consent’ and; (2) percentage 
of young women unvaccinated during ‘stage 1’ minus 
percentage of young women unvaccinated during ‘stage 
1’, ‘stage 2’ and ’stage 3: community catch up clinics and 
family practices’).
To show whether there was an unintended increase or 
reduction in health inequalities, we compared the risk 
differences and corresponding p values by school cate-
gory, ethnic group and deprivation quintile—comparing 
with a baseline category in each case.
Analyses were undertaken using the Stata, release V.15 
(Stata).
RESULTS
Data were extracted relating to 7549 young women 
eligible for vaccination during the intervention period 
(programme years 2017/2018–2018/2019). Of these, 420 
(5.6%) were excluded on the basis that the school data 
was missing or invalid.
Of the cohort retained for analysis (n=7129), the 
majority of vaccine eligible young women were resident in 
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local authority one (4516, 63.4%), attended comprehen-
sive, non- fee paying schools (6350, 89.1%), and were clas-
sified as belonging to a white British ethnic group (4888, 
68.6%). Of young women eligible for vaccination, 6341 
(89.0%) were recorded to have received the HPV vaccine 
during the programme year they were eligible. Parental 
consent forms were recorded as being unreturned 
(comprising active refusal and passive non- consent) for 
1555 (16.2%) of eligible young women (table 1).
Return of parental consent forms
Variables associated with return of parental consent forms 
are provided as unadjusted ORs in table 2. After adjusting 
for school category, ethnicity and deprivation, an asso-
ciation was found between parental consent form not 
being returned and: attending an alternative education 
provider setting (adjusted OR (aOR): 5.54, 95% CI: 3.80 
to 8.09, p<0.001), belonging to a non- white British (aOR: 
1.34, 95% CI: 1.06 to 1.70, p<0.01) and unknown ethnicity 
category (aOR: 2.41, 95% CI: 2.09 to 2.78, p<0.001). 
There was also evidence for a relationship with level of 
deprivation. For example, young women belonging to the 
most deprived quintile had at least double the odds of 
having a record of unreturned consent form (aOR: 2.54, 
95% CI: 2.03 to 3.18, p<0.001) compared with those from 
the least deprived quintile (table 2).
Percentage of young women unvaccinated by stage of 
implementation of consent procedures
Following implementation of stage 1 (parental written 
consent) of the consent procedures, 1519 (21.3%) of 
young women were unvaccinated. At stage 2 (parental 
verbal consent and adolescent self- consent), this reduced 
to 1173 (16.5%) unvaccinated young women. With the 
inclusion of stage 3 (community catch up clinics and 
family practice settings), there remained 788 (11.1%) 
unvaccinated young women during the study period 
(table 3). Not all parents could be contacted by the 
immunisation team on the day of the vaccination session 
(n=362). These parents were not routinely contacted 
again by the immunisation team (data not shown).
The percentage of unvaccinated young women varied 
by school category at different stages of implementa-
tion of the consent procedures. For example, at stage 1 
(parental written consent only), 20.6% of young women 
who attended mainstream comprehensive, non- fee- paying 
schools were unvaccinated, in comparison to 50.8% who 
attended alternative education provider settings. At stage 
Table 1 Descriptive summary of eligible cohort by vaccine receipt and return of parent consent form
Eligible cohort HPV vaccine received Unreturned parent consent form
n (%) n (%) n (%)
  7129 (100.0) 6341 (89.0) 1155 (16.2)
Area level
Local authority 1 4516 (63.4) 3944 (87.3) 843 (18.7)
Local authority 2 2613 (36.7) 2397 (91.7) 312 (11.9)
Programme year 2017/2018 3581 (50.2) 3202 (89.4) 565 (15.8)
Programme year 2018/2019 3548 (49.8) 3139 (88.5) 590 (16.6)
School category
Comprehensive, non- fee paying 6350 (89.1) 5690 (89.6) 992 (15.6)
Private, fee paying 661 (9.3) 565 (85.5) 105 (15.9)
Alternative education providers 118 (1.7) 86 (72.9) 58 (49.2)
Individual level
Ethnicity
White British 4888 (68.6) 4552 (93.1) 610 (12.5)
Non- white British 572 (8.0) 492 (86.0) 101 (17.7)
Unknown 1669 (23.4) 1297 (77.7) 444 (26.6)
Deprivation
Least deprived 1348 (18.9) 1235 (91.6) 136 (10.1)
Quintile 2 1379 (19.3) 1277 (92.6) 149 (10.8)
Quintile 3 1403 (19.7) 1273 (90.7) 210 (15.0)
Quintile 4 1396 (19.6) 1203 (86.2) 292 (20.9)
Most deprived 1421 (19.9) 1194 (84.0) 338 (23.8)
Unknown 182 (3.6) 159 (87.4) 30 (16.5)
HPV, human papillomavirus.
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2 (parental verbal consent and adolescent self- consent), 
there was no evidence for narrowing of this gap (p=0.27). 
However, after stage 3 (community catch- up clinics and 
family practice settings), the decrease in unvaccinated 
young women was greater for those that attended alter-
native education provider settings, compared with those 
who attended comprehensive, non- fee paying schools 
(accumulative risk difference: 23.7% vs 10.2%, p<0.001) 
(figure 1 and table 3).
There were also differences by ethnicity. At stage 1 
(parental written consent only), 15.8% of white British 
young women were unvaccinated, in comparison to 
26.7% of non- white British young women and 35.7% 
belonging to the unknown ethnic category. Following 
implementation of stage 2 (parental verbal consent and 
adolescent self- consent), the percentage unvaccinated 
decreased at a greater rate in young women classified as 
‘unknown’ ethnic category compared with white British 
young women (risk difference: 6.7% vs 4.2%, p<0.001), 
but no difference was observed for non- white British 
young women (p=0.21). There was evidence for a differ-
ence with the inclusion of stage 3 for non- white British 
women (accumulative risk difference: 12.8% vs 8.9%, 
p=0.01) and unknown ethnicity (accumulative risk differ-
ence: 13.4% vs 8.9%, p<0.001) (figure 1 and table 3).
Inequalities in the percentage of unvaccinated young 
women by deprivation were attenuated by each stage of 
implementation of the policy. At stage 1 (parental written 
consent only), 14.2% young women in the least deprived 
quintile were unvaccinated in comparison to 29.8% of 
young women in the most deprived quintile. Subsequent 
to stage 2 (parental verbal consent and adolescent self- 
consent), the percentage of unvaccinated young women 
decreased at a greater rate for those belonging to the 
most deprived quintile compared with the least deprived 
quintile (risk difference: 7.4% vs 2.3%, p<0.001). A similar 
pattern was observed following implementation of stage 3 
(community catch- up clinics and family practice settings) 
(overall risk difference: 13.8% vs 5.8%, p<0.001) (figure 1 
and table 3).
DISCUSSION
The HPV vaccination programme has been implemented 
to prevent acquisiton of HPV, a recognised precursor 
to developing cervical cancer. The findings from this 
study show that some of the barriers to young women 
being vaccinated were overcome through the imple-
mentation of a new local policy, which included parental 
verbal consent and adolescent self- consent in the school 
setting. There is promising evidence that the additional 
steps have the potential to reduce existing inequalities 
in uptake among young women living in more deprived 
areas. Importantly, this study showed that these young 
women are less likely to engage with consent procedures 
that rely on paper- based methods, are more likely to be 
affected by cervical cancer,5 15 and less likely to receive the 
HPV vaccine.6
The majority of young women were vaccinated in 
the school setting. However, this study supports the 
Table 2 Associations of unreturned parental consent form with school category, ethnicity and deprivation
 
N (%) Form not returned OR (95% CI)* P value aOR (95% CI)* P value
  – – – –
School category n (%)
Comprehensive, non- fee 
paying
6350 992 (15.6) – –
Private, fee paying 661 105 (15.9) 1.02 (0.82 to 1.27) 0.86 1.12 (0.89 to 1.43) 0.34
Alternative education 
providers
118 58 (49.2) 5.22 (3.62 to 7.54) <0.001 5.54 (3.80 to 8.09) <0.001
Ethnicity
White British 4888 610 (12.5) – – – –
Non- white British 572 101 (17.7) 1.50 (1.19 to 1.89) <0.01 1.34 (1.06 to 1.70) 0.01
Unknown 1669 444 (26.6) 2.54 (2.21 to 2.92) <0.001 2.41 (2.09 to 2.78) <0.001
Deprivation
Least deprived 1279 136 (10.1) – –
Quintile 2 1324 149 (10.8) 1.08 (0.84 to 1.38) 0.54 1.09 (0.85 to 1.40) 0.48
Quintile 3 1334 210 (15.0) 1.57 (1.25 to 1.97) <0.001 1.57 (1.24 to 1.98) <0.001
Quintile 4 1305 292 (20.9) 2.36 (1.89 to 2.93) <0.001 2.24 (1.79 to 2.81) <0.001
Most deprived 1347 338 (23.8) 2.78 (2.24 to 3.45) <0.001 2.54 (2.03 to 3.18) <0.001
Unknown 182 30 (16.4) 1.75 (1.14 to 2.70) 0.01 1.52 (0.97 to 2.37) 0.07
*Adjusted for ethnicity, deprivation, school category and clustering by school.
aOR, adjusted OR.
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provision of the HPV vaccine in community settings, such 
as catch- up clinics and general practice surgeries, to help 
improve access to vaccination. This may benefit young 
women who may have had anxieties about being vacci-
nated without a parent or carer present, or did not attend 
school on the day of the vaccination session.
Community provision of the HPV vaccine also appeared 
to reduce substantial inequalities in uptake among young 
women educated in alternative education provider 
settings. The reasons for this are unclear, but could relate 
to their lower school attendance, complex behavioural 
and physical health needs, or perceptions of safety of 
vaccination in the school setting due to interactions 
with other medical treatment. Although they comprise 
a small proportion of the overall vaccine- eligible popula-
tion, they are a vulnerable groups with substantially lower 
uptake and greater health inequalities which requires 
addressing.
As the majority of parents who could be contacted 
provided verbal consent, the data imply that the absence 
of a signed parental consent form cannot be assumed to 
mean the parent does not want their daughter to have the 
vaccine. Not all parents could be contacted by the immu-
nisation team on the day of the vaccination session. Provi-
sion of additional resources to contact families ahead of 
the vaccination session could help reduce the proportion 
of families who are not contacted and help ensure that 
their daughter receives the HPV vaccine if they wish.
Relative to parental verbal consent, adolescent self- 
consent occurred infrequently. Our analyses of qualita-
tive data from this study showed a strong presumption 
that parents should make decisions affecting the health 
of their children. The preferred age at which the HPV 
vaccination is administered (12–13 years) also contrib-
uted to reluctance in endorsing self- consent which 
was thought to have the potential to break down trust 
between parents and school staff, and within families.16 
This suggests that unresolved issues could act as a barrier 
to widespread implementation of adolescent self- consent 
in other settings.
Our primary statistical analyses for this study showed 
that the new consent procedures increased uptake by 
11% in one of the intervention local authorities, and 
appeared to overcome trends for decreasing uptake in 
matched sites.11 Our secondary analyses of the process 
evaluation data reported here showed an additional 347 
young women (4.8%) received the HPV vaccine in the 
school setting. All things being equal, if changes in policy 
resulted in similar effect sizes in other local authorities, 
as part of a strategy to increase uptake, then the English 
HPV vaccination programme could reach the WHO’s 
target of 90% of young women receiving the vaccination 
by 15 years old.17
Additionally, establishing the cost- effectiveness of strat-
egies to improve uptake of vaccination programmes is 
important to provide evidence for policy- makers to target 
Figure 1 Percentage of HPV vaccine eligible young women unvaccinated by stage of implementation of consent procedure. 
HPV, human papillomavirus.
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resources appropriately. This has been established in the 
context of the USA,18 but these findings are not easily 
translatable to English schools- based, rather than health-
carebased, vaccination programmes.
Public Health England have recently issued updated 
guidance for healthcare professionals related to the new 
universal HPV vaccination programme.19 This supports 
the use of parent verbal consent and adolescent self- 
consent as strategies to maximise uptake and reduce 
catch- up sessions. They cite further benefit of inclusion 
of young people whose parents may have difficulties in 
completing the consent due to language or literacy issues. 
The findings from this study provide evidence that strate-
gies incorporating parent verbal consent could help young 
women belonging to ‘harder- to- reach’ families receive the 
HPV vaccine. These recommendations may also be appli-
cable to other schools- based vaccination programmes, 
including the influenza vaccination programme offered 
to primary school- aged children where similar patterns in 
forms returns have been reported.20
Strengths and limitations
The study has some strengths. This is the first study to 
examine how new local polices for the HPV vaccina-
tion programme are implemented, and the impact on 
health inequalities among more deprived populations 
and minority ethnicity groups. Our study used routinely 
collected data related to vaccination status, eliminating 
the risk of recall and selection bias. The data relate to 
vaccinations delivered in school and community settings 
to all young women eligible for routine HPV vaccination 
during the study period. As such, our results correspond 
to an almost complete population.
There are some limitations. The data related to imple-
mentation of new consent procedures in a geographically 
distinct area in the south- west of England. The findings 
therefore may not be applicable to local authorities that 
are implementing new consent procedures in schools- 
based vaccination programmes elsewhere in the UK. The 
findings may also not translate to other adolescent vacci-
nation programmes delivered in countries where cultural 
differences may influence the acceptability of parental 
verbal consent and adolescent self- consent procedures in 
the school setting.
As the study relied on routinely collected information, 
we did not have access to individual- level measures of 
socioeconomic status and relied on area- based measures 
of deprivation. Our study findings may therefore be 
subject to ecological fallacy.
An issue, common to all routinely collected data, is the 
possibility of data input errors and missing data. To mini-
mise bias from inclusion of this data, we excluded almost 
5% of the data as the information related to school was 
out- of- date. Overall, our dataset identified 8% of young 
women belonging to a minority ethnic group. This 
compares with nationally reported figures indicating) 
30% of young people attending secondary schools in the 
intervention areas belong to a non- white ethnic group.21 
Missing ethnicity data (23%) relating to young women 
who were born outside the local authority boundaries 
could change the direction or size of aORs corresponding 
to ethnicity.
CONCLUSIONS
Introducing further steps to the consent procedures—
allowing parents to consent verbally and adolescent self- 
consent—overcame some of the barriers to vaccination of 
young women belonging to families less likely to respond 
to paper- based methods of gaining consent.
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•Consent forms sent home via school to parents
•School collate forms for the vaccination session
•Young women with signed consent forms receive the HPV vaccine
Parental verbal consent & adolescent self-
consent
Stage Two
•For young women without signed consent forms, parents telephoned for opportunity to 
verbally consent
•Young women asked whether discussion about vaccination had taken place at home
•Young women assessed for self-consent by immunisation team
Community catch-up clinics & family practice
Stage Three
•Unvaccinated young women are provided with written information about community catch-
up clinics
•Some young women may also choose to be vaccinated in the family practice setting
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